Cognizant Technology Solutions
CTSH
$62.54
+2.11%
Cognizant Technology Solutions is a multinational IT services provider specializing in consulting and business process outsourcing. It leverages a global delivery model, primarily from India, to serve enterprise clients across financial services, healthcare, and other key industries.…
CTSH
Cognizant Technology Solutions
$62.54
Investment Opinion: Should I buy CTSH Today?
Based on a synthesis of the data, the objective assessment is a Hold. The stock's valuation is undeniably cheap on a forward earnings basis, and its financial strength provides a margin of safety. However, the powerful downtrend, severe underperformance, and lack of a clear near-term growth catalyst suggest the stock may remain under pressure. Investors should wait for evidence of a technical bottom forming or an improvement in business momentum before considering a new Buy rating.
Sign up to view all
CTSH 12-Month Price Forecast
The data paints a picture of a fundamentally sound company caught in a severe bear market move. The risk/reward is becoming more balanced after the steep decline, but the lack of positive momentum suggests patience is warranted.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Cognizant Technology Solutions's 12-month outlook, with a consensus price target around $81.30 and implied upside of +30.0% versus the current price.
Average Target
$81.30
12 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
12
covering this stock
Price Range
$50 - $81
Analyst target range
Wall Street analysts provide coverage with an average estimated EPS of $6.26 for the coming period, ranging from $6.14 to $6.36. Estimated average revenue is $24.74 billion. Recent institutional ratings show a mix of opinions, including 'Buy' or 'Overweight' from Guggenheim and Wells Fargo, 'Hold' or 'Equal Weight' from TD Cowen and Morgan Stanley, and 'Neutral' from Citigroup and UBS. This indicates a consensus view that is cautious to moderately positive, with no strong sell ratings among recent actions.
Bulls vs Bears: CTSH Investment Factors
CTSH presents a classic value vs. momentum conflict. The company's strong balance sheet, cash flow, and low forward P/E are compelling bullish fundamentals. However, these are overshadowed by severe technical damage, weak relative strength, and signs of slowing growth, which justify the bearish price action. The stock appears to be pricing in significant pessimism.
Bullish
- Attractive Forward Valuation: Forward P/E of 9.99 is low, suggesting potential upside if earnings stabilize.
- Strong Financial Health: Low debt (D/E 0.10), high liquidity (Current Ratio 2.34), and robust $2.6B FCF.
- Solid Profitability Metrics: Healthy ROE of 14.85% and ROA of 10.23% indicate efficient operations.
- Deeply Oversold Technically: Price is near 52-week low, down 26% in 3 months, indicating potential for a rebound.
Bearish
- Severe Price Downtrend: Stock down 31% from recent highs, underperforming S&P 500 significantly.
- Weak Recent Growth: Q4 revenue grew only 4.94% YoY, with net income showing volatility.
- High Short Interest: Short ratio of 3.87 indicates significant bearish sentiment from traders.
- Margin Pressure: Net margin declined sequentially in 2025, from 12.96% in Q1 to 12.15% in Q4.
CTSH Technical Analysis
The stock has experienced a significant downtrend over the observed 180-day period, declining from a high near $87 in December 2025 to a current price of $61.35. This represents a substantial correction, with the price now trading near the lower end of its 52-week range of $58.84 to $87.03.
Short-term performance has been weak, with the stock down 4.78% over the past month and down 26.08% over the past three months. This underperformance is notable compared to the broader market, as indicated by negative relative strength figures of 0.47 (1-month) and -21.45 (3-month).
The current price of $61.35 is just 4.3% above the 52-week low of $58.84, indicating the stock is in a deeply oversold position relative to its recent trading range. The price has fallen sharply from its peak, reflecting significant selling pressure and negative sentiment.
Beta
0.98
0.98x market volatility
Max Drawdown
-31.1%
Largest decline past year
52-Week Range
$59-$87
Price range past year
Annual Return
-18.5%
Cumulative gain past year
| Period | CTSH Return | S&P 500 |
|---|---|---|
| 1m | -2.8% | -3.6% |
| 3m | -23.1% | -4.0% |
| 6m | -7.6% | -2.0% |
| 1y | -18.5% | +16.2% |
| ytd | -23.1% | -3.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CTSH Fundamental Analysis
Revenue in the latest quarter (Q4 2025) was $5.33 billion, representing a year-over-year growth of 4.94%. However, net income of $648 million in Q4 2025 showed a significant sequential decline from $663 million in Q1 2025, indicating potential margin pressure or one-time items affecting profitability during the year.
The company maintains a strong financial position with a low debt-to-equity ratio of 0.10 and a healthy current ratio of 2.34, suggesting ample liquidity. Free cash flow over the trailing twelve months was a robust $2.6 billion, supporting shareholder returns through dividends and buybacks.
Operational efficiency metrics are solid, with a return on equity (ROE) of 14.85% and return on assets (ROA) of 10.23%. The net margin for the latest quarter was 12.15%, though this has shown some quarterly volatility throughout 2025.
Quarterly Revenue
$5.3B
2025-12
Revenue YoY Growth
+0.04%
YoY Comparison
Gross Margin
+0.31%
Latest Quarter
Free Cash Flow
$2.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CTSH Overvalued?
Given the company's positive net income, the primary valuation metric is the P/E ratio. The trailing P/E ratio is 17.90, while the forward P/E is 9.99 based on estimated EPS of $6.26. The forward P/E suggests the market has priced in significant earnings growth or a discount due to recent performance concerns.
Other valuation metrics include a price-to-sales ratio of 1.89 and an EV/EBITDA of 9.49. The price-to-book ratio is 2.66. Peer comparison data is not available in the provided inputs to contextualize these multiples against industry averages.
PE
17.9x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 12x~30x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.5x
Enterprise Value Multiple
Investment Risk Disclosure
The primary risk is the continuation of the severe downtrend, driven by negative market sentiment and potential fundamental deterioration not yet fully reflected in financials. The high short interest (ratio 3.87) acts as a near-term overhang and could lead to increased volatility. Operational risks include margin compression, as seen in the sequential decline in net income through 2025, and the challenge of reigniting revenue growth above the mid-single-digit rate in a competitive IT services market.
Financial risk is low due to the strong balance sheet with minimal debt and high liquidity. However, valuation risk is present; while the forward P/E looks cheap, the high PEG ratio suggests the market has little confidence in future growth, creating a 'value trap' scenario if earnings estimates are revised downward. Macroeconomic risks affecting IT spending and potential currency headwinds from its global delivery model are additional considerations.
FAQ
Key risks include the continuation of the sharp price downtrend, high short interest (ratio 3.87) pressuring the stock, and potential margin pressure as seen in recent quarterly net income volatility. There is also a risk that slow revenue growth (4.94% YoY in Q4) persists, preventing a valuation re-rating despite the low P/E.
The 12-month outlook is mixed. The base case (60% probability) sees a range of $62-$72, implying a recovery from oversold levels as earnings meet estimates. The bull case targets $75-$87 on improved sentiment, while the bear case could see a retest of the $58-$62 range. Analyst consensus EPS is $6.26, providing a fundamental anchor.
Based on forward earnings, CTSH appears undervalued with a P/E of 9.99, which is low for a profitable IT services company. However, the high PEG ratio of 20.2 suggests the market is pricing in very low growth, creating a 'value trap' risk. The stock trades near its 52-week low, further supporting the undervalued argument from a price perspective.
CTSH is a contentious buy at current levels. Its forward P/E of 9.99 and strong balance sheet are attractive for value investors. However, the severe 26% three-month decline and high short interest indicate significant negative sentiment. It may be suitable for patient investors with a long-term horizon, but risky for short-term traders.
CTSH is more suitable for a long-term investment horizon. The current technical weakness and sentiment-driven sell-off could persist in the short term. Long-term investors can look through this volatility to the company's solid profitability (ROE 14.85%), strong cash flow ($2.6B FCF), and cheap valuation, which may be rewarded over several years.